A recent study sought to examine the risk of depression among young women. Researchers at the University of California, Los Angeles, studied the psychiatric health of 155 female high school students, aged 17 to 18 years at the beginning of the study, over a period of five years to collect data. It was found that 47 percent of the participants had at least one episode of major depression within five years after high school graduation and that the risk peaked at about 18-19 years of age; bouts of depression during the study period were the first such episodes in about 37 percent of women. Authors note that the risk of depression was greatest in those women with a prior history of depression and that both academic pressure and relationships were strongly associated with the risk. The study is in “The Journal of the American Academy of Child and Adolescent Psychiatry”
This post has been viewed 38 times.
Related posts:
- Vitamin B12 Deficiency Linked to Depression in Older Women Brenda Penninx, Ph.D., and colleagues from The Johns Hopkins University, the University of Colorado in Denver and Vrije University in the Netherlands have found a positive correlation between vitamin B12 (cobalamin) deficiency and depression in physically disabled elderly women. Data from the Women’s...
- Antidepressants May Cut Heart Attack Risk Prozac, Paxil, Zoloft help prevent blood clots A new study supports the theory that one kind of antidepressant drug can help prevent heart disease not only by relieving the burden of depression but also by preventing blood clots, say researchers. There is still...
- Work May Trigger Anxiety in Women Job stress found to cause a variety of mental ailments. Being overworked and underchallenged are job-related stress issues that for women may lead to depression, anxiety and feelings of hostility, according to a study of a group of women employed by a large...
- SSRI class of antidepressants: pregnant and breastfeeding women Treating clinical depression in pregnant and breastfeeding mothers has always required assessing the risk of using a psychotropic medication, which might affect a developing fetus, against the benefits of preventing a mother from becoming incapacitated with depressive symptoms. Increasing experience with the selective...
- Drug sertraline (Zoloft) therapy for controlling symptoms of premenstrual syndrome A new study suggests that the antidepressant drug sertraline (Zoloft), from Pfizer Inc., may be effective in controlling symptoms of premenstrual syndrome (PMS). * Researchers at Scott & White Memorial Hospital in Temple, Texas, randomized 57 women diagnosed with moderate-to-severe premenstrual syndrome (PMS)...
